" class="no-js "lang="en-US"> Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO) - Medtech Alert
Saturday, February 04, 2023

Immunologix Laboratories Appoints Dr. Corinna Fiorotti As Chief Commercial Officer (CCO)

Immunologix Laboratories announced today that Dr. Corinna Fiorotti has been appointed Chief Commercial Officer. An experienced science and business leader, Dr. Fiorotti assumed responsibilities on August 1, 2022 and will oversee all aspects of Immunologix Laboratories commercial function, including business development, marketing, and commercial growth

“We are fortunate to have someone of Dr. Fiorotti’s caliber and experience step up to lead the commercial operation, including the business development team, at Immunologix” said Michael Anderson, President and CEO. “Corinna is strategically positioned for the role of CCO as she has a deep understanding of our business from both the scientific and business points of view and brings a strong track record of business success. As a member of our unique Translational Sciences team at Immunologix for the past 2 years, Dr. Fiorotti has built an in-depth understanding of our services and the market. She is a strong communicator who is customer focused and possesses operational and leadership capabilities to successfully execute on the company’s strategy and growth plans”

Dr. Fiorotti holds a Ph.D. in Microbiology and Immunology and has worked in drug development for 19 years, with combined experience from both Sponsor and CRO organizations. She therefore brings a comprehensive perspective to the business development endeavors at Immunologix and is uniquely positioned to serve as CCO.

Fiorotti said, “I am honored and excited to lead the commercial team at Immunologix Laboratories. It is a privilege to be part of an organization that delivers such high caliber bioanalytical and biomarker services and innovative scientific solutions to our clients to help them bring lifesaving therapies to patients. Immunologix has an exceptional scientific team that is truly passionate about the work we do.  Our culture is built around a commitment to high quality science for our clients and providing scientific growth opportunities for our staff. We are an organization led by purpose, to make a positive, meaningful impact on the client projects that we support and thereby to improving the lives of patients.”

People In This Post

Companies In This Post

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more